Data Gathering for A10900
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorOptos, PLC
About this trial
The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
Participants 22 years of age or older on the date of informed consent
Participants able to understand the written informed consent and willing to participate as evidenced by signing the informed consent
BCVA 20/400 or better in the study eye
Participants presenting at the site with retinal disease
Trial population
Participants with healthy, glaucoma, retinal disease and corneal disease located in different geographic locations in the US
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
OCT
DeviceA10900 is an optical coherence tomography device
Treatment groups
180 Participants
are divided into 4 treatment groupsGroup A: Retinal Disease1 intervention
Group B: Healthy1 intervention
Group C: Glaucoma1 intervention
Group D: Corneal Disease1 intervention
Trial outcomes
Primary outcomes
1
Number of OCT Scans
Time frame
1 year Source ClinicalTrials.gov